Correlation Between Sutro Biopharma and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Sutro Biopharma and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sutro Biopharma and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sutro Biopharma and Cue Biopharma, you can compare the effects of market volatilities on Sutro Biopharma and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sutro Biopharma with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sutro Biopharma and Cue Biopharma.
Diversification Opportunities for Sutro Biopharma and Cue Biopharma
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Sutro and Cue is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Sutro Biopharma and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Sutro Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sutro Biopharma are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Sutro Biopharma i.e., Sutro Biopharma and Cue Biopharma go up and down completely randomly.
Pair Corralation between Sutro Biopharma and Cue Biopharma
Given the investment horizon of 90 days Sutro Biopharma is expected to under-perform the Cue Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Sutro Biopharma is 2.31 times less risky than Cue Biopharma. The stock trades about -0.12 of its potential returns per unit of risk. The Cue Biopharma is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 66.00 in Cue Biopharma on September 2, 2024 and sell it today you would earn a total of 56.00 from holding Cue Biopharma or generate 84.85% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sutro Biopharma vs. Cue Biopharma
Performance |
| Timeline |
| Sutro Biopharma |
| Cue Biopharma |
Sutro Biopharma and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sutro Biopharma and Cue Biopharma
The main advantage of trading using opposite Sutro Biopharma and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sutro Biopharma position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Sutro Biopharma vs. Tff Pharmaceuticals | Sutro Biopharma vs. Eliem Therapeutics | Sutro Biopharma vs. Inhibrx | Sutro Biopharma vs. Enliven Therapeutics |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |